160 related articles for article (PubMed ID: 26592833)
1. Efficacy of paclitaxel in the treatment of Kaposi sarcoma.
Ercolak V; Sahin B; Gunaldi M; Duman BB; Afsar CU
Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4095-100. PubMed ID: 26592833
[TBL] [Abstract][Full Text] [Related]
2. A case of relapsed visceral Kaposi's sarcoma with bilateral chylothoraces successfully treated with paclitaxel.
Natarajan P; Miller A
Int J STD AIDS; 2015 Jul; 26(8):605-9. PubMed ID: 25122577
[TBL] [Abstract][Full Text] [Related]
3. Treatment of classical type Kaposi's sarcoma with paclitaxel.
Chao SC; Lee JY; Tsao CJ
Anticancer Res; 2001; 21(1B):571-3. PubMed ID: 11299806
[TBL] [Abstract][Full Text] [Related]
4. Clearance of recurrent, classical Kaposi's sarcoma using multiple paclitaxel treatments.
Osawa R; Kato N; Yanagi T; Yamane N
Acta Derm Venereol; 2007; 87(5):435-6. PubMed ID: 17721656
[No Abstract] [Full Text] [Related]
5. Treatment with taxanes of refractory or life-threatening Kaposi sarcoma not associated with human immunodeficiency virus infection.
Fardet L; Stoebner PE; Bachelez H; Descamps V; Kerob D; Meunier L; Dandurand M; Morel P; Lebbe C
Cancer; 2006 Apr; 106(8):1785-9. PubMed ID: 16534786
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel as first- or second-line treatment for HIV-negative Kaposi's sarcoma: a retrospective study of 58 patients.
Tourlaki A; Germiniasi F; Rossi LC; Veraldi S; Brambilla L
J Dermatolog Treat; 2020 Mar; 31(2):183-185. PubMed ID: 30897011
[No Abstract] [Full Text] [Related]
7. Weekly paclitaxel for advanced aggressive classic Kaposi sarcoma: experience in 17 cases.
Brambilla L; Romanelli A; Bellinvia M; Ferrucci S; Vinci M; Boneschi V; Miedico A; Tedeschi L
Br J Dermatol; 2008 Jun; 158(6):1339-44. PubMed ID: 18363766
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel for AIDS-associated Kaposi's sarcoma.
Dhillon T; Stebbing J; Bower M
Expert Rev Anticancer Ther; 2005 Apr; 5(2):215-9. PubMed ID: 15877519
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma.
Gill PS; Tulpule A; Espina BM; Cabriales S; Bresnahan J; Ilaw M; Louie S; Gustafson NF; Brown MA; Orcutt C; Winograd B; Scadden DT
J Clin Oncol; 1999 Jun; 17(6):1876-83. PubMed ID: 10561228
[TBL] [Abstract][Full Text] [Related]
10. Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma.
Tulpule A; Groopman J; Saville MW; Harrington W; Friedman-Kien A; Espina BM; Garces C; Mantelle L; Mettinger K; Scadden DT; Gill PS
Cancer; 2002 Jul; 95(1):147-54. PubMed ID: 12115328
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment with paclitaxel of advanced AIDS-associated Kaposi's sarcoma.
Kobayashi M; Takaori-Kondo A; Shindo K; Mizutani C; Ishikawa T; Uchiyama T
Intern Med; 2002 Dec; 41(12):1209-12. PubMed ID: 12521218
[TBL] [Abstract][Full Text] [Related]
12. Treatment of recurrent Kaposi's sarcoma of an AIDS patient with weekly paclitaxel.
Hsu CH; Chen MY; Cheng AL
Anticancer Res; 2000; 20(2B):1159-61. PubMed ID: 10810414
[TBL] [Abstract][Full Text] [Related]
13. [Refractory AIDS-associated Kaposi's sarcoma treated successfully with paclitaxel: a case report].
Kato H; Yanagisawa N; Sasaki S; Hosoda T; Suganuma A; Imamura A; Ajisawa A
Kansenshogaku Zasshi; 2012 May; 86(3):287-90. PubMed ID: 22746051
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of chemotherapeutics in classic and non-classic Kaposi sarcoma: A single-center retrospective real-world data.
Oyucu Orhan S; Bilgehan Sahin A; Cubukcu E; Deligonul A; Ocak B; Orhan B; Evrensel T
Bosn J Basic Med Sci; 2021 Dec; 21(6):746-751. PubMed ID: 33596402
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel for relapsed or recurrent HIV-associated pediatric Kaposi's sarcoma.
Reddy-Holdcraft S; Mehta PS; Agrawal AK
AIDS; 2014 Mar; 28(5):800-2. PubMed ID: 24983546
[No Abstract] [Full Text] [Related]
16. Posttransplant Kaposi's sarcoma treated with paclitaxel.
Wu CJ; Scadden DT
J Clin Oncol; 1998 Oct; 16(10):3478-9. PubMed ID: 9779728
[No Abstract] [Full Text] [Related]
17. Efficacy of docetaxel in disseminated classical Kaposi's sarcoma.
Stoebner PE; Nocera T; Meynadier J; Meunier L
Br J Dermatol; 2000 Dec; 143(6):1357-9. PubMed ID: 11122073
[No Abstract] [Full Text] [Related]
18. Complete response to second line Paclitaxel every 2 weeks of eyelid kaposi sarcoma: a case report.
Brunetti AE; Guarini A; Lorusso V; Minoia C; Sabatelli A; Marech I; Silvestris N
Ophthalmic Plast Reconstr Surg; 2013; 29(5):e114-5. PubMed ID: 23247036
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment with three-weekly paclitaxel of an anthracycline-refractory classical Kaposi's sarcoma.
Silvestris N; Galetta D; Colucci G
Anticancer Res; 2009 Feb; 29(2):675-6. PubMed ID: 19331220
[TBL] [Abstract][Full Text] [Related]
20. Anti-cancer agents. A new treatment for Kaposi's sarcoma?
TreatmentUpdate; 2002; 14(7):6-8. PubMed ID: 12400501
[No Abstract] [Full Text] [Related]
[Next] [New Search]
